For the quarter ending 2025-09-30, UTMD made $9,812,000 in revenue. $2,255,000 in net income. Net profit margin of 22.98%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Sales, net | 9,812,000 | 9,953,000 | 9,710,000 | 10,249,000 |
| Cost of goods sold | 4,208,000 | 4,358,000 | 4,172,000 | 4,205,000 |
| Gross profit | 5,604,000 | 5,595,000 | 5,538,000 | 6,044,000 |
| Sales and marketing | - | - | - | 475,250 |
| Selling, general and administrative | 2,826,000 | 2,264,000 | 2,231,000 | - |
| Research & development | 167,000 | 135,000 | 154,000 | 193,000 |
| General and administrative | - | - | - | 1,958,750 |
| Total operating expense | 2,993,000 | 2,399,000 | 2,385,000 | - |
| Operating income | 2,611,000 | 3,196,000 | 3,153,000 | 3,406,500 |
| Royalty income (note 12) | - | - | - | 3,750 |
| Other income | 698,000 | 640,000 | 705,000 | -891,500 |
| Dividend and interest income | - | - | - | 1,687,250 |
| Income before provision for income taxes | 3,309,000 | 3,836,000 | 3,858,000 | 4,206,000 |
| Provision for income taxes | 678,000 | 788,000 | 817,000 | 777,000 |
| Net income | 2,631,000 | 3,048,000 | 3,041,000 | 3,429,000 |
| Foreign currency translation net of taxes of 0 in all periods | -376,000 | 1,828,000 | 718,000 | -1,324,000 |
| Total comprehensive income | 2,255,000 | 4,876,000 | 3,759,000 | 2,105,000 |
| Earnings per common share (diluted) | 0.82 | 0.94 | 0.92 | 0.98 |
| Earnings per share, basic | 0.82 | 0.94 | 0.92 | 0.98 |
| Shares outstanding - basic | 3,207,000 | 3,246,000 | 3,310,000 | -1,753,500 |
| Shares outstanding - diluted | 3,207,000 | 3,246,000 | 3,310,000 | -1,753,500 |
UTAH MEDICAL PRODUCTS INC (UTMD)
UTAH MEDICAL PRODUCTS INC (UTMD)